Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from the Food and Drug Administration

Here's what really happened during the abortion drug's approval 23 years ago

A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.

WEKU

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

Tribune News Service

Editorial: Judge had a basis for his attack on FDA, but not regarding mifepristone

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

St. Louis Post-Dispatch

From analysis to the latest developments in health,
read the most diverse news in one place.

To protect abortion access, the FDA should decline to enforce a mifepristone ban

Try as it might, the Food and Drug Administration cannot escape the abortion debate. The agency must be bolder

The Guardian - US

Big tobacco targets Black smokers with menthol but FDA plans a ban

ATLANTA — The Food and Drug Administration has taken up the regulation of tobacco products as a key issue to focus on in 2023, particularly prohibiting the sale of menthol cigarettes and flavored cigars and cigarillos.

Tribune News Service

Commentary: A judge’s attempt to restrict medication abortion nationwide shows extremists aren’t done yet

On Friday, federal Judge Matthew Kacsmaryk handed down a decision further restricting abortion access nationwide by suspending the Food and Drug Administration’s approval of mifepristone, the most common and safe pill used for medication abortion. Another ruling, from a federal judge in Washington state, ordered the F.D.A. to make no…

Los Angeles Times

Medication abortion is still possible with just one drug. Here's how it works

A judge's ruling puts access to the abortion drug mifepristone in limbo, pending further court decisions. But there's another drug that is safe and effective at ending early pregnancy.

WEKU

Read news from The Economist, FT, and more,
with one subscription

US abortion pill access in doubt after Texas judge suspends approval

Abortion medication mifepristone has been available in the US for more than 20 years

Evening Standard

US access to abortion pill mifepristone in limbo after conflicting judicial rulings

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

France 24

Abortion pill ruling: Texas judge orders hold on FDA approval, but another judge contradicts him

ATLANTA — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

Los Angeles Times

Unsafe cadmium level detected in seaweed product

The Food and Drug Administration (FDA) has warned people not to consume a certain lot of roasted nori seaweed products due to potential contamination of cadmium.

Bangkok Post

FDA forces unproven premature birth drug Makena off market

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

The Independent UK

FDA warns public of toxic hair dye

The Food and Drug Administration (FDA) on Tuesday warned consumers that three South Korean hair-dyeing products contain cancer-causing chemicals.

Bangkok Post

Starbucks recall - 300,000 bottled Frappuccino drinks recalled

We share everything you need to know about the Starbucks recall, as 300,000 drinks are pulled from shelves.

GoodToKnow

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

The FDA may soon authorize a spring round of COVID-19 boosters for some people

The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older.

WEKU

The FDA approves the overdose-reversing drug Narcan for over-the-counter sales

The decision could make the life-saving drug more accessible. Emergent BioSolutions, the drug company that produces Narcan, said it anticipates it will be on store shelves by late summer.

Bangkok Post

Parents warned, kids eating smuggled cannabis cookies

The Food and Drug Administration (FDA) has warned parents to be alert after "many children" in the south were hospitalised after eating smuggled cannabis-infused cookies containing excessive levels of psychoactive tetrahydrocannabinol (THC).

The Orange County Register

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

Get all your
news in one place.

100's of premium titles.
One news app.

Asharq Al-Awsat

COVID-19 Pill Paxlovid Moves Closer to Full FDA Approval

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from US health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.

WEKU

Sickle cell patient's success with gene editing raises hopes and questions

A Mississippi woman's life has been transformed by a treatment for sickle cell disease with the gene-editing technique CRISPR. All her symptoms from a disease once thought incurable have disappeared.

Tribune News Service

Judge weighs FDA approval of abortion drug

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

The Independent UK

Medication abortions are under fire: Here's how they work

Medication abortions became the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade

The Independent UK

Abortion pill hearing made public after transparency concern

A judge is set to hear arguments in a lawsuit that poses a threat to the nationwide availability of medication abortion

Ballotpedia

Democratic attorneys general sue Biden administration over FDA abortion pill regulation

A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the World Health Organization

the Centers for Disease Control and Prevention

240 stories

the Food and Drug Administration

224 stories

5th Circuit

154 stories

the Alzheimer Association

49 stories

Whole Woman Health

26 stories

Alzheimer Association

20 stories

the American College of Obstetricians and Gynecologists

18 stories

the Alliance for Hippocratic Medicine

14 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.